These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3037894)

  • 1. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP; Raij L
    Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of intraglomerular pressure in the initiation and progression of renal disease.
    Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
    Dunn BR; Zatz R; Rennke HG; Meyer TW; Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S251-4. PubMed ID: 3033178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL; Rennke HG; Brenner BM; Anderson S
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
    Thaiss F; Haas C; Helmchen U; Wenzel U; Stahl RA
    Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
    Hollenberg NK; Raij L
    Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
    Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
    J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.
    Garcia DL; Rennke HG; Brenner BM; Anderson S
    J Clin Invest; 1987 Sep; 80(3):867-74. PubMed ID: 3040810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.